Evidence of myocardial edema in patients with nonischemic dilated cardiomyopathy

Clinical Cardiology

Volumn 35, Issue 6, 2012, Pages 371-376

  Jeserich, Michael ^a   Föll, Daniela ^a   Olschewski, Manfred ^a   Kimmel, Simone ^d   Friedrich, Matthias G ^b,c   Bode, Christoph ^a   Geibel, Annette ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b MONTREAL HEART INSTITUTE   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d Private Practice Cardiology and Angiology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAPHY; FEMALE; GENDER; HEART EDEMA; HEART EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC DIAMETER; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE VOLUME; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HUMAN; MALE; MYOCARDIAL EDEMA; MYOCARDITIS; SYSTOLIC BLOOD PRESSURE;

EID: 84862173818     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.21979     Document Type: Article

References (34)

1. Nieminen MS, Harjola VP. Definition and epidemiology of acute heart failure syndromes. Am J Cardiol. 2005;19:5G-10G. (Pubitemid 41338069)
2. Dayer M, Cowie MR. Heart failure: diagnosis and health care burden. Clin Med. 2004;4:13-18. (Pubitemid 38252178)
3. Sampietro T, Neglia D, Bionda A, et al. Inflammatory markers and serum lipids in idiopathic dilated cardiomyopathy. Am J Cardiol. 2005;96:1718-1720. (Pubitemid 41790397)
4. Heymans S, Hirsch E, Anker SD, et al. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Failure. 2009;11:119-129.
5. Noutsias M, Pauschinger M, Poller WC, et al. Current insights into the pathogenesis, diagnosis and therapy of inflammatory cardiomyopathy. Heart Fail Monit. 2003;3:127-135.
6. Kuhl U, Noutsias M, Seeberg B, et al. Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart. 1996;75:295-300. (Pubitemid 26094969)
7. DiBona, DR, Powell WJ Jr. Quantitative correlation between cell swelling and necrosis in myocardial ischemia in dogs. Circ Res. 1980;47:653-665.
8. Laine GA, Allen SJ. Left ventricular myocardial edema. Lymph flow, interstitial fibrosis, and cardiac function. Circ Res. 1991;68:1713-1721.
9. Friedrich MG. Myocardial edema-a new clinical entity? Nat Rev Cardiol. 2010;7:292-296.
10. Abdel-Aty H, Simonetti O, Friedrich MG. T2-weighted cardiovascular magnetic resonance imaging. Magn Reson Imaging. 2007;26:452-459. (Pubitemid 350194566)
11. Abdel-Aty H, Zagrosek A, Schulz-Menger J, et al. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation. 2004;109:2411-2416. (Pubitemid 38679560)
12. Berry C, Kellman P, Mancini C, et al. Magnetic resonance imaging delineates the ischemic area at risk and myocardial salvage in patients with acute myocardial infarction. Circ Cardiovasc Imaging. 2010;3:527-535.
13. Cury, RC, Shash K, Nagurney JT, et al. Cardiac magnetic resonance with T2-weighted imaging improves detection of patients with acute coronary syndrome in the emergency department. Circulation. 2008;118:837-844.
14. Vignaux O, Dhote R, Duboc D, et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest. 202;122:1895-1901.
15. Marie PY, Angioi M, Carteaux JP, et al. Detection and prediction of acute heart transplant rejection with the myocardial T2 determination provided by a black-blood magnetic resonance imaging sequence. J Am Coll Cardiol. 2001;37:825-831. (Pubitemid 32202451)
16. Muellerleile K, Lund G, Groth M, et al. Delayed-enhancement magnetic resonance imaging in patients with clinically suspected stress cardiomyopathy (Tako-tsubo). Rofo. 2010;182:29-35.
17. Abdel-Aty H, Cocker M, Friedrich MG. Myocardial edema is a feature of Tako-Tsubo cardiomyopathy and is related to the severity of systolic dysfunction: insights from T2-weighted cardiovascular magnetic resonance. Int J Cardiol. 2009;132:291-293.
18. Jeserich M, Olschewski M, Bley TH, et al. Cardiac involvement after respiratory tract viral infection - detection by cardiac magnetic resonance. J Comput Assist Tomogr. 2009;33:15-19.
19. Abdel-Aty H, Boye P, Zagrosek A, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol. 2005;45:1815-1822. (Pubitemid 40779862)
20. Assomull RG, Lyne JC, Keenan N, et al. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin and unobstructed coronary arteries. Eur Heart J. 2007;28:1242-1249. (Pubitemid 47343853)
21. Gutberlet M, Spors B, Thoma T, et al. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology. 2008;246:401-409.
22. White JA, Patel MR. The role of cardiovascular MRI in heart failure and the cardiomyopathies. Cardiol Clin. 2007;25:71-95, vi. (Pubitemid 46661974)
23. Friedrich MG, Sechtem U, Holmvang G, et al International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol. 2009;53:1475-1487.
24. Jeserich M, Konstantinides S, Olschewski M, et al. Diagnosis of early myocarditis after respiratory or gastrointestinal tract viral infection: insights from cardiovascular magnetic resonance. Clin Res Cardiol. 2010;99:707-714.
25. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342:1077-1084. (Pubitemid 30207690)
26. Dec GW Jr, Palacios IF, Fallon JT, et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies: clinical features, histologic correlates, and clinical outcome. N Engl J Med. 1985;312:885-890. (Pubitemid 15105673)
27. Feldman AM, McNamara D. Myocarditis. N Engl J Med. 2000;343:1388-1398.
28. Spotnitz MD, Lesch M. Idiopathic dilated cardiomyopathy as a late complication of healed viral (Coxsackie B virus) myocarditis: historical analysis, review of the literature, and a postulated unifying hypothesis. Prog Cardiovasc Dis. 2006;49:42-57. (Pubitemid 44080801)
29. Caforio AL, Iliceto S. Genetically determined myocarditis: clinical presentation and immunological characteristics. Curr Opin Cardiol. 2008;23:219-226. (Pubitemid 351492465)
30. Zagrosk A, Wassmuth R, Abdel-Aty H, et al. Relation between myocardial edema and myocardial mass during the acute and convalescent phase of myocarditis - a CMR study. J Cardiovasc Magn Reson. 2008;10:19-27.
31. Voigt A, Elgeti T, Durmus T, et al. Cardiac magnetic resonance imaging in dilated cardiomyopathy in adults - towards identification of myocardial inflammation. Eur Radiol. 2011;21:925-935.
32. Tang WH. The year in heart failure. J Am Coll Cardiol. 2010;55:688-696.
33. Unverferth DV, Baker PB, Swift SE, et al. Extent of myocardial fibrosis and cellular hypertrophy in dilated cardiomyopathy. Am J Cardiol. 1986;57:816-820. (Pubitemid 16054340)
34. Roberts WC, Siegel RJ, McManus BM. Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol. 1987;60:1340-1355.